US-based Nomad Health, a healthcare staffing start-up, has laid off 17 per cent of its workforce this week, amid tough macroeconomic conditions
Canadian Prime Minister Justin Trudeau said Tuesday that Canada's health care system isn't living up to its promise, and he plans to add billions more in funding. Trudeau said wait times in emergency departments have become dangerously long, people are waiting too long for essential surgeries and millions of Canadians are without a family doctor. "For generations, public health care has been a core part of what it means to be Canadian. It's built on a promise that no matter where you live, or what you earn, you will always be able to get the medical care you need. But right now, our health care system isn't living up to that promise," Trudeau said. "Canadians deserve better," he said. Trudeau's Liberal Party government has presented a new health care funding offer that would see Ottawa shift Canadian Dollar 196 billion (USD 146 billion) over the next 10 years to the provinces and territories, which oversee health care in the country. The government has set conditions for the extra
Diarrhoea cases in villages of Hamirpur district's Nadaun sub-division are estimated to have crossed 1,200 in the last three days, Health department officials said on Tuesday. The exact figure will be available later in the day, they said. According to government data, 868 cases were reported till Monday night. Of the total, one patient is undergoing treatment at the hospital. Nadaun is the assembly constituency of Himachal Pradesh Chief Minister Sukhvinder Singh Sukhu. Preliminary tests of water samples have not indicated any contamination, Jal Shakti department officials said. Neeraj Bhogal, a superintending engineer in the department, said water samples of all schemes on Kunah khad would be taken daily and sent to a laboratory in Chandigarh. The Chandigarh lab is better equipped for such tests. Until the water quality is ascertained, it will not be supplied, he said. Water to the affected villages is supplied from nearby khads under various schemes of the Jal Shakti ...
Scientists have developed a new biomaterial that can be injected intravenously, reduces inflammation in tissue and that could be used to repair the damage to cardiac tissue resulting from a heart attack. The researchers at the University of California (UC) San Diego, US, also provided proof of concept in a rodent model that the biomaterial could be beneficial to patients with traumatic brain injury and pulmonary arterial hypertension, the study said. The biomaterial was tested and proven effective in treating tissue damage caused by heart attacks in both rodent and large animal models, according to the study. "This biomaterial allows for treating damaged tissue from the inside out," said Karen Christman, a professor at UC San Diego, and the lead researcher on the team that developed the material. "It's a new approach to regenerative engineering," said Christman. A study on the safety and efficacy of the biomaterial in human subjects could start within one to two years, Christman .
The coronavirus remains a global health emergency, the World Health Organization chief said Monday, after a key advisory panel found the pandemic may be nearing an inflexion point where higher levels of immunity can lower virus-related deaths. Speaking at the opening of WHO's annual executive board meeting, WHO Director-General Tedros Adhanom Ghebreyesus said there is no doubt that we're in a far better situation now than a year ago when the highly transmissible Omicron variant was at its peak. But Tedros warned that in the last eight weeks, at least 1,70,000 people have died around the world in connection with the coronavirus. He called for at-risk groups to be fully vaccinated, an increase in testing and early use of antivirals, an expansion of lab networks, and a fight against misinformation about the pandemic. "We remain hopeful that in the coming year, the world will transition to a new phase in which we reduce hospitalizations and deaths to the lowest possible level, he ...
Scientists have developed a blood-based test that could be used to predict the risk of Alzheimer's disease up to 3.5 years before clinical diagnosis. The research, published in the journal Brain, supports the idea that components in the human blood can modulate the formation of new brain cells, a process termed neurogenesis. Neurogenesis occurs in an important part of the brain called the hippocampus that is involved in learning and memory. While Alzheimer's disease affects the formation of new brain cells in the hippocampus during the early stages of the disease, previous studies have only been able to study neurogenesis in its later stages through autopsies. To understand the early changes, researchers collected blood samples over several years from 56 individuals with Mild Cognitive Impairment (MCI), a condition where someone will begin to experience a worsening of their memory or cognitive ability. While not everyone experiencing MCI goes on to develop Alzheimer's disease, tho
Chinas health authorities have said the Covid-19 wave is past its peak, with rapid decline in both severe cases and deaths in hospitals, but experts remain wary of the governments official data
Macleods Pharmaceuticals is recalling around 10,000 bottles of generic antibiotic medication in the US market due to a labelling error, according to the US health regulator. As per the latest enforcement report by the US Food and Drug Administration (USFDA), Macleods Pharma Inc, a US-based unit of the company, is recalling 10,052 bottles of Levofloxacin tablets, which are used to treat different types of bacterial infections. The company is recalling the affected lot due to"mismatching of the embossing on the tablets with the embossing mentioned in the package insert in the distributed bottles." Macleods manufactured the affected lot in its Baddi-based manufacturing plant in Himachal Pradesh. The company initiated the Class III recall in the US and Puerto Rico on January 5. As per the USFDA, a Class III recall is initiated in a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences. The US generic drug market was estimate
Covid has highlighted the need for adequate infrastructure and health care workforce, especially doctors and nurses
Dr Reddy's Laboratories on Wednesday reported a 77 per cent increase in its consolidated net profit at Rs 1,247 crore in the third quarter ended December 31, 2022. The drug firm had reported a net profit of Rs 706 crore in the October-December period of the previous fiscal. Revenue from operations rose to Rs 6,770 crore during the period under review as against Rs 5,320 crore in the year-ago period, Dr Reddy's Laboratories said in a regulatory filing.
Just as the ECG sensor on your health app uses electrical sensors on the back of the wearable wristband to measure heart health, EEG sensors embedded in ear buds can measure brain health
Hospitals are expected to report a soft Q3 result due to a mix of seasonality and easing pent-up demand, however, average revenue per occupied bed is likely to remain steady
MoS Health said that emergency preparedness was no longer an initiative in isolation, but rather "an overarching priority" which "requires efforts to build resilient health systems
Stocks to Watch: Infosys and HCL Technologies to announce Q3 results; Sah Polymers to debut on Thursday.
State govt tells revellers to end New Year celebrations before 1 am; Centre readies for mock drills today
The airport tests are aimed at a 2 per cent sample of all incoming international travellers
Less than 30,000 booster doses daily in December, vaccine coverage flat for two months
Tamil Nadu health minister Ma Subramanian said incentives would be provided to all those who work for the Makkalai Thedi Maruthuvam scheme
Reports suggest that Union Health Minister Mansukh Mandaviya will review the Covid-19 pandemic situation, in view of a spurt in COVID-19 cases in Japan, South Korea, Brazil, China and the US.
Hello Logistics Inc., which operates under the name NextMed, sued Mehta, his business partner Tejasvi Singh, and their company Cloud Health Systems over allegations of misappropriation of trade secret